SOLUTIONS
Flagship diagnostic Service: MMVD-VetVision DXC
MMVD-VetVision DXC is our precision diagnostic test for canine myxomatous mitral valve disease, the most common heart disease in dogs. This test can reveal at-risk patients that are “invisible” to current standard methods, or reclassify misdiagnosed cases. By catching the disease early or clarifying its stage, veterinarians can initiate timely interventions and provide personalized care to improve outcomes.
Case Study Luna: Early Detection in Canine Cardiology
Luna, a 4-year-old dog with no apparent symptoms, was diagnosed with early-stage Myxomatous Mitral Valve Disease (MMVD) through Moovet’s advanced miRNA-based diagnostic test. Thanks to this early detection, her veterinarian was able to initiate a timely treatment plan—significantly improving her quality of life and long-term health outlook.
Adoption rate
Veterinarian feedback
95% of veterinary clinics surveyed indicated a high interest in adopting our MMVD diagnostic test to enhance clinical decision-making and practice efficiency. Join your colleagues who already trust our innovation!
Frequently Asked Question
What is MMVD?
Myxomatous Mitral Valve Disease (MMVD) is the most common heart disease in dogs. It involves the progressive deterioration of the mitral valve, leading to blood regurgitation in the heart, which can result in congestive heart failure.
It is chronic but manageable, especially if diagnosed early【ISVMA†source】.
It is chronic but manageable, especially if diagnosed early【ISVMA†source】.
How many dogs are affected by MMVD in Europe?
How many dogs are affected by MMVD in Europe?
There are over 106 million dogs in Europe. According to veterinary research:
- About 10–20% of dogs are affected by MMVD → 10 to 20 million animals
- Prevalence exceeds 75% in dogs over 6 years of age in predisposed breeds
- Each year, millions of cases go undiagnosed, especially in the early stages
There are over 106 million dogs in Europe. According to veterinary research:
- About 10–20% of dogs are affected by MMVD → 10 to 20 million animals
- Prevalence exceeds 75% in dogs over 6 years of age in predisposed breeds
- Each year, millions of cases go undiagnosed, especially in the early stages
What are the most common heart diseases in dogs?
Myxomatous Mitral Valve Disease (MMVD) is the most frequent: it affects about 4 in 10 dogs. Other conditions include:
- Dilated cardiomyopathies
- Tricuspid valve dysplasia
- Arrhythmias
- Congenital malformations
- Dilated cardiomyopathies
- Tricuspid valve dysplasia
- Arrhythmias
- Congenital malformations
Why is MMVD underdiagnosed?
MMVD is underdiagnosed for several reasons:
- It is a chronic disease, initially silent or asymptomatic: in early stages, the dog may show no clear symptoms, making it hard for the owner to notice
- Until recently, the only reliable diagnostic test was echocardiography, a test that is:
- Expensive per session
- Available only in specialized clinics or with an in-house veterinary cardiologist
- Technically complex, and often not feasible in many local veterinary practices
- Only a small fraction of owners request advanced cardiac exams without symptoms, leading to late diagnoses when heart damage is already advanced.
Updated data show that in Italy, about 10% of dogs have a heart condition, but only a fraction receive a timely diagnosis.
Thanks to the new MMVD VetVision DXC test, based on blood sampling and predictive biomarkers, early, accessible, and repeatable screening is now possible even in non-specialized clinics, overcoming the limits of traditional echocardiography.
- It is a chronic disease, initially silent or asymptomatic: in early stages, the dog may show no clear symptoms, making it hard for the owner to notice
- Until recently, the only reliable diagnostic test was echocardiography, a test that is:
- Expensive per session
- Available only in specialized clinics or with an in-house veterinary cardiologist
- Technically complex, and often not feasible in many local veterinary practices
- Only a small fraction of owners request advanced cardiac exams without symptoms, leading to late diagnoses when heart damage is already advanced.
Updated data show that in Italy, about 10% of dogs have a heart condition, but only a fraction receive a timely diagnosis.
Thanks to the new MMVD VetVision DXC test, based on blood sampling and predictive biomarkers, early, accessible, and repeatable screening is now possible even in non-specialized clinics, overcoming the limits of traditional echocardiography.
What does a missed or late diagnosis mean for my dog's health?
A late diagnosis can lead to:
- Irreversible disease progression
- Congestive heart failure
- Reduced quality of life
- Disability and premature death
Early diagnosis allows targeted therapies to begin, slowing progression and prolonging your dog’s life.
- Irreversible disease progression
- Congestive heart failure
- Reduced quality of life
- Disability and premature death
Early diagnosis allows targeted therapies to begin, slowing progression and prolonging your dog’s life.
How is MMVD diagnosed today?
Traditionally:
- Auscultation to detect heart murmurs
- Echocardiography to confirm the diagnosis
Today, the MMVD VetVision DXC test is available:
- Simple blood draw
- High accuracy thanks to molecular biomarkers (miRNA)
- Predictive, even before symptom onset
- Auscultation to detect heart murmurs
- Echocardiography to confirm the diagnosis
Today, the MMVD VetVision DXC test is available:
- Simple blood draw
- High accuracy thanks to molecular biomarkers (miRNA)
- Predictive, even before symptom onset
How can I avoid delays in diagnosis and starting therapy?
Ask for early screening, especially if your dog is over 6 years old or belongs to a high-risk breed.
- Ask for early screening, especially if your dog is over 6 years old or belongs to a high-risk breed.
- The MMVD VetVision DXC test allows for predictive diagnosis with a simple blood draw, without stress for the animal.
- Visit your veterinarian at least once a year, even in the absence of symptoms.
- Ask for early screening, especially if your dog is over 6 years old or belongs to a high-risk breed.
- The MMVD VetVision DXC test allows for predictive diagnosis with a simple blood draw, without stress for the animal.
- Visit your veterinarian at least once a year, even in the absence of symptoms.
In which dogs is MMVD most common?
It mainly affects small and medium-sized dogs. Predisposed breeds include the Cavalier King Charles Spaniel (up to 100% risk after 6 years of age), Poodle, Chihuahua, Maltese, Yorkshire Terrier, and Shih-Tzu.
Age is an important factor: the risk increases from 6 years onward.
Age is an important factor: the risk increases from 6 years onward.
My dog is young. Can it develop MMVD?
Yes. In predisposed breeds, MMVD can begin as early as 3–5 years of age. For this reason, it is useful to carry out check-ups even in young dogs, especially if they are small or have a family history.
Which signs should I never ignore?
If you notice one or more of these symptoms, contact your veterinarian immediately:
- Persistent cough
- Labored breathing
- Fatigue after mild exertion
- Excessive thirst
- Loss of appetite
- Persistent cough
- Labored breathing
- Fatigue after mild exertion
- Excessive thirst
- Loss of appetite
How is MMVD diagnosed today?
Traditionally:
- Auscultation to detect heart murmurs
- Echocardiography to confirm the diagnosis
Today, the MMVD VetVision DXC test is available:
- Simple blood draw
- High accuracy thanks to molecular biomarkers (miRNA)
- Predictive, even before the onset of symptoms
- Auscultation to detect heart murmurs
- Echocardiography to confirm the diagnosis
Today, the MMVD VetVision DXC test is available:
- Simple blood draw
- High accuracy thanks to molecular biomarkers (miRNA)
- Predictive, even before the onset of symptoms
Can MMVD be treated?
MMVD is treatable. Treatments include:
- Cardioprotective medications
- Specific diets
- Regular veterinary check-ups
With the right therapy, your dog can live a long and healthy life. Talk to your veterinarian.
- Cardioprotective medications
- Specific diets
- Regular veterinary check-ups
With the right therapy, your dog can live a long and healthy life. Talk to your veterinarian.
My dog has no symptoms. Is the test necessary?
Yes. The test is specifically meant to catch the disease before it’s too late. Early diagnosis is your dog’s best ally.
How much does the MMVD VetVision DXC test cost?
The recommended retail price is €100, much lower than a cardiology visit with echocardiography. It is accessible, repeatable, and also suitable for routine screening.
Do I need to repeat the test?
Yes, especially for at-risk dogs:
- Every 12 months for dogs over 6 years old
- Every 6 months for dogs already affected or predisposed
- Every 12 months for dogs over 6 years old
- Every 6 months for dogs already affected or predisposed
How can I improve the lifespan and quality of life of my dog with MMVD?
There are four concrete actions:
- Early diagnosis → screening even before symptoms appear
- Tailored therapy → medications, diet, check-ups
- Stable and stress-free routine
- Ongoing monitoring with the veterinarian
Many dogs live peaceful, long lives with MMVD if properly followed.
- Early diagnosis → screening even before symptoms appear
- Tailored therapy → medications, diet, check-ups
- Stable and stress-free routine
- Ongoing monitoring with the veterinarian
Many dogs live peaceful, long lives with MMVD if properly followed.
How does the VetVision DXC test for MMVD work?
- Non-invasive: only requires a blood sample
- Fast and accurate: provides predictive indications before symptoms appear
- Available in all veterinary clinics
- Economically accessible (not expensive compared to periodic echocardiography)
- Fast and accurate: provides predictive indications before symptoms appear
- Available in all veterinary clinics
- Economically accessible (not expensive compared to periodic echocardiography)
How can we help your veterinary clinic?
Moovet provides non-invasive, miRNA-based diagnostics to help you detect diseases early, personalize treatments, and improve clinical outcomes. Easy to use, scientifically validated, and supported by our expert team.
Are you interested in research collaborations?
Yes, Moovet actively collaborates with veterinary researchers and institutions. We welcome partnerships for clinical studies, biomarker discovery, and technology validation.
Want to know more about our technology?
Our patented miRNA-based platform enables non-invasive, precise diagnostics for veterinary medicine. It’s fast, reliable, and built for clinical use.
TESTIMONIALS